THERAPLAS Trademark

Trademark Overview


On Wednesday, March 8, 2023, a trademark application was filed for THERAPLAS with the United States Patent and Trademark Office. The USPTO has given the THERAPLAS trademark a serial number of 97828627. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, March 4, 2025. This trademark is owned by Imunon, Inc.. The THERAPLAS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Development of platform technology, namely, cancer immunotherapy, infectious disease, and gene therapy platforms for manufacturing therapeutics; Biological and biotechnology research; research and development in the pharmaceutical and biotechnology fields; scientific research and development with regard to the manufacture of pharmaceutical preparations; chemical and biological analysis; development of pharmaceutical preparations for treating cancer; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific and technological research in the fields of genetics, immunotherapy, vaccination, and oncology
theraplas

General Information


Serial Number97828627
Word MarkTHERAPLAS
Filing DateWednesday, March 8, 2023
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, March 4, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 4, 2025

Trademark Statements


Goods and ServicesDevelopment of platform technology, namely, cancer immunotherapy, infectious disease, and gene therapy platforms for manufacturing therapeutics; Biological and biotechnology research; research and development in the pharmaceutical and biotechnology fields; scientific research and development with regard to the manufacture of pharmaceutical preparations; chemical and biological analysis; development of pharmaceutical preparations for treating cancer; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific and technological research in the fields of genetics, immunotherapy, vaccination, and oncology

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, March 28, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameImunon, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLawrenceville, NJ 08648

Party NameImunon, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLawrenceville, NJ 08648

Trademark Events


Event DateEvent Description
Saturday, March 11, 2023NEW APPLICATION ENTERED
Tuesday, March 28, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, December 6, 2023ASSIGNED TO EXAMINER
Wednesday, December 13, 2023NON-FINAL ACTION WRITTEN
Wednesday, December 13, 2023NON-FINAL ACTION E-MAILED
Wednesday, December 13, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 13, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 13, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 13, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 22, 2024LETTER OF SUSPENSION E-MAILED
Monday, April 22, 2024SUSPENSION LETTER WRITTEN
Monday, April 22, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, January 24, 2025SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Tuesday, February 11, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 26, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 4, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 4, 2025PUBLISHED FOR OPPOSITION